Global Blood Therapeutics announces closing of public offering of common stock
Global Blood Therapeutics announced the closing of its underwritten public offering of 5,867,347 shares of its common stock at a price to the public of $24.50 per share, which includes 765,306 additional shares of common stock issued upon the exercise in full of the underwriter’s option. February 27, 2017